RXi Pharmaceuticals Corporation (RXII.O)

RXII.O on Consolidated Issue listed on NASDAQ Capital Market

4.63USD
3:59pm EST
Price Change (% chg)

$0.13 (+2.89%)
Prev Close
$4.50
Open
$4.75
Day's High
$4.75
Day's Low
$4.51
Volume
212,139
Avg. Vol
361,006
52-wk High
$7.57
52-wk Low
$1.51

RXII.O

Chart for RXII.O

About

RXi Pharmaceuticals Corporation (RXi) is a discovery-stage biopharmaceutical company pursuing therapeutics based on ribonucleic acid interference (RNAi) for the treatment of human diseases. The Company is focused on internal research and development programs on certain inflammatory and metabolic diseases, and to pursue other... (more)

Overall

Beta: 0.40
Market Cap (Mil.): $76.66
Shares Outstanding (Mil.): 16.21
Annual Dividend: 0.00
Yield (%): NA

Financials

  RXII.O Industry Sector
P/E (TTM): -- 12.69 4.64
EPS (TTM): -8.70 -- --
ROI: -180.26 1.36 2.82
ROE: -181.16 2.20 3.58
view overview for:

Competitors

  Price Change
Alnylam Pharmaceuticals, Inc. (ALNY.OQ) $17.79 +0.43
Merck & Co., Inc. (MRK.N) $37.25 -0.50
MDRNA, Inc. (MRNA.OQ) $1.00 -0.03
Benitec Ltd. (BLT.AX) $0.04 -0.00
Silence Therapeutics plc (SLN.L) £18.50 -0.25
Rosetta Genomics Ltd. (USA) (ROSG.OQ) $1.77 +0.12
ISIS Pharmaceuticals, Inc. (ISIS.OQ) $11.17 +0.73

  Earnings  vs    Estimates

view overview for: